Skip to search formSkip to main contentSkip to account menu

ciprofibrate

Known as: 2-(4-(2,2-dichlorocyclopropyl)phenoxy)2-methylpropanoic acid, 2-(P-(2,2-Dichlorocyclopropyl)Phenoxy)-2-Methylpropionic Acid, Propanoic Acid, 2-(4-(2,2-Dichlorocyclopropyl)Phenoxy)-2-Methyl- 
A fibrate derivative with antilipidemic activity.
National Institutes of Health

Related topics

Related topics

6 relations

Broader (4)

Clofibric AcidFibric AcidsHypolipidemic AgentsPeroxisome Proliferators

Narrower (2)

LipanorOroxadin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Ciprofibrate stimulates the gastrin-producing cell by acting luminally on antral PPAR α Running head : Mechanisms of ciprofibrate-induced hypergastrinemia
Background: The lipid-lowering drug ciprofibrate stimulates gastrin-producing cells in the rat stomach without lowering gastric… 
2005
2005
Ciprofibrate diminishes non-HDL-c and improves HDL-c in patients with frederickson type IV dyslipidemia phenotype
Hypertriacylglyceridemia and low HDLc combination is one of the most common lipidic abnormalities. Thus, the aim of this study… 
2001
2001
Ciprofibrate Increases Plasma Concentration of Platelet-Derived Growth Factor AB in Patients with Advanced Atherosclerosis and Hyperlipidemia Independently of Its Hypolipidemic Effects
Fibrates, besides their hypolipidemic action, share alternative effects, such as decreased plasma fibrinogen and uric acid levels… 
2000
2000
Rapid determination of rat hepatocyte mRNA induction potential using oligonucleotide probes for CYP1A1, 1A2, 3A and 4A1
1. A new assay to quantify mRNA levels in small numbers of rat hepatocytes has been developed for cytochrome P450 (CYP) isoforms… 
1998
1998
The effect of the peroxisome proliferator ciprofibrate on the gastric mucosa and particularly the gastrin cell.
The peroxisome proliferator ciprofibrate induces hypergastrinemia without inhibiting acid secretion. The present study was… 
1997
1997
The effect of deferoxamine on ciprofibrate-induced hepatocarcinogenesis in the rat.
BACKGROUND: Peroxisome proliferators (PP) are proven hepatocarcinogens in rats and mice. The carcinogenic effect of PP has been… 
1996
1996
Preliminary report: Ciprofibrate-fluvastatin combination therapy for dyslipidaemia
Correcting abnormalities in the lipid profile is beneficial in reducing the risk of myocardial infarction. Recent studies… 
1996
1996
Polymyosite médicamenteuse induite par le ciprofibrate
L'ensemble des medicaments hypolipemiants peut etre responsable d'effets secondaires en particulier musculaires, d'intensite… 
1992
1992
Long-term efficacy and safety of ciprofibrate in patients with primary hyperlipidemia
1990
1990
[Acute rhabdomyolysis during treatment with ciprofibrate].